Biological Products: Principles of Pharmaceutical Biotechnology, Clinical Challenges, Manufacturing Prospects, and Regulatory Horizons

Biological Products: Principles of Pharmaceutical Biotechnology, Clinical Challenges, Manufacturing Prospects, and Regulatory Horizons

SAEID MASOUDNIA1 farshad asodeh2 ali jamali3 mohammad yousefi kordsarakohi4 hossein atashgahi5

1) Bachelor s Student in Chemical Industry Technology Engineering, University of Applied Science and Technology (UAST), Azin Khodro Manufacturing and Industrial Company Training Center, Tehran, Iran
2) Bachelor s Student in Chemical Industry Technology Engineering, University of Applied Science and Technology (UAST), Azin Khodro Manufacturing and Industrial Company Training Center, Tehran, Iran
3) Bachelor s Student in Chemical Industry Technology Engineering, University of Applied Science and Technology (UAST), Azin Khodro Manufacturing and Industrial Company Training Center, Tehran, Iran
4) Bachelor s Student in Chemical Industry Technology Engineering, University of Applied Science and Technology (UAST), Azin Khodro Manufacturing and Industrial Company Training Center, Tehran, Iran
5) Bachelor s Student in Chemical Industry Technology Engineering, University of Applied Science and Technology (UAST), Azin Khodro Manufacturing and Industrial Company Training Center, Tehran, Iran

IOI Code : ACCD-ACZZAD
Publication : 10th International Conference on Applied Researches in Science & Engineering (carseconf.com)
Abstract :
    Biologics, as one of the most dynamic and transformative pillars of modern pharmaceuticals, have revolutionized therapeutic approaches in oncology, immunology, hematology, and rare genetic diseases. Unlike small molecules, which are characterized by low molecular weight, well-defined chemical structures, and synthetic origins, biologics are complex, heterogeneous macromolecules. They are highly sensitive to three-dimensional conformation and post-translational modifications (PTMs), and are produced through biological systems and recombinant DNA technology. This review article provides a comprehensive overview of biosynthesis, expression systems, upstream and downstream processing, physicochemical characterization, immunogenicity, formulation and stability challenges, biosimilars, and emerging trends such as cell and gene therapies (CGT) and the application of artificial intelligence in process optimization.

Keywords : biological products expression systems artificial intelligence